These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21677229)

  • 1. Intranasal oxytocin as an adjunct to escitalopram in major depression.
    Scantamburlo G; Ansseau M; Geenen V; Legros JJ
    J Neuropsychiatry Clin Neurosci; 2011; 23(2):E5. PubMed ID: 21677229
    [No Abstract]   [Full Text] [Related]  

  • 2. Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial.
    Scantamburlo G; Hansenne M; Geenen V; Legros JJ; Ansseau M
    Eur Psychiatry; 2015 Jan; 30(1):65-8. PubMed ID: 25282363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained.
    Bech P; Allerup P; Larsen ER; Csillag C; Licht RW
    Acta Psychiatr Scand; 2013 Apr; 127(4):328-9. PubMed ID: 23480386
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
    Fantino B; Moore N; Verdoux H; Auray JP
    Int Clin Psychopharmacol; 2007 Mar; 22(2):107-15. PubMed ID: 17293711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram/reboxetine combination in depressed patients with substance use disorder.
    Camarasa X; Lopez-Martinez E; Duboc A; Khazaal Y; Zullino DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):165-8. PubMed ID: 15610962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other?
    Uher R; Mors O; McGuffin P
    Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials.
    Li H; Li T; Li G; Luo J
    Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram for the treatment of major depression and anxiety disorders.
    Höschl C; Svestka J
    Expert Rev Neurother; 2008 Apr; 8(4):537-52. PubMed ID: 18416657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C; Schmotz C; Sarubin N; Baghai TC; Laenger A; Lieb M; Bondy B; Rupprecht R; Schüle C
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to antidepressant combinations and monotherapy for major depressive disorder: a CO-MED report of measurement-based care.
    Warden D; Trivedi MH; Carmody T; Toups M; Zisook S; Lesser I; Myers A; Kurian KR; Morris D; Rush AJ
    J Psychiatr Pract; 2014 Mar; 20(2):118-32. PubMed ID: 24638046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study.
    Bergman J; Miodownik C; Bersudsky Y; Sokolik S; Lerner PP; Kreinin A; Polakiewicz J; Lerner V
    Clin Neuropharmacol; 2013; 36(3):73-7. PubMed ID: 23673908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Oxytocin System to Ameliorate Early Life Depressive-Like Behaviors in Maternally-Separated Rats.
    Abdelwahab LA; Galal OO; Abd El-Rahman SS; El-Brairy AI; Khattab MM; El-Khatib AS
    Biol Pharm Bull; 2021 Oct; 44(10):1445-1457. PubMed ID: 34349049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antidepressant therapy for major depressive disorder: speed and probability of remission.
    Stewart JW; McGrath PJ; Blondeau C; Deliyannides DA; Hellerstein D; Norris S; Amat J; Pilowsky DJ; Tessier P; Laberge L; O'Shea D; Chen Y; Withers A; Bergeron R; Blier P
    J Psychiatr Res; 2014 May; 52():7-14. PubMed ID: 24485847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram.
    Ho PS; Yeh YW; Huang SY; Liang CS
    Psychoneuroendocrinology; 2015 Mar; 53():246-55. PubMed ID: 25647343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.